EPCAM and neoplasm: Notably, the only responders to the immunotherapy-alone condition (patient 5 and patient 6) correlated with an increased percentage of total CD3+ T cell populations (Figure 5D) and PD-L1 expression in EPCAM+ circulating tumor cells (Figure 5G).